E617 20 (Opana ER 20 mg)
Generic Name: oxymorphone
Pill imprint E617 20 has been identified as Opana ER 20 mg.
Opana ER is used in the treatment of pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Opana ER 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Opana ER
- Generic Name:
- oxymorphone
- Imprint:
- E617 20
- Strength:
- 20 mg
- Color:
- Green
- Shape:
- Eight-sided
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Endo Pharmaceuticals Inc.
- National Drug Code (NDC):
- 63481-0617
- Inactive Ingredients:
- hypromelloses
methylparaben
sodium stearyl fumarate
titanium dioxide
triacetin
polyethylene glycol
polysorbate 80
FD&C Blue No. 1
FD&C Yellow No. 6
D&C Yellow No. 10
Submitted by: Drugs.com
More about Opana ER (oxymorphone)
Consumer resources
- Other brands: Numorphan
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
